261 related articles for article (PubMed ID: 37305017)
1. Galectins dysregulation: A way for cancer cells to invade and pervade.
Abdelfattah MM; Helwa R
Oncol Res; 2022; 30(3):129-135. PubMed ID: 37305017
[TBL] [Abstract][Full Text] [Related]
2. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
[TBL] [Abstract][Full Text] [Related]
3. Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications.
Mohamed RM; Emam A; Abdelfattah MM; Abdel-Mageed AI; Abdelhafeez MA; Helwa R
World J Surg Oncol; 2022 Sep; 20(1):276. PubMed ID: 36050693
[TBL] [Abstract][Full Text] [Related]
4. The Role of Galectins in Tumor Progression, Treatment and Prognosis of Gynecological Cancers.
Chetry M; Thapa S; Hu X; Song Y; Zhang J; Zhu H; Zhu X
J Cancer; 2018; 9(24):4742-4755. PubMed ID: 30588260
[TBL] [Abstract][Full Text] [Related]
5. Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor.
Nagy N; Bronckart Y; Camby I; Legendre H; Lahm H; Kaltner H; Hadari Y; Van Ham P; Yeaton P; Pector JC; Zick Y; Salmon I; Danguy A; Kiss R; Gabius HJ
Gut; 2002 Mar; 50(3):392-401. PubMed ID: 11839721
[TBL] [Abstract][Full Text] [Related]
6. Galectins-1, -3, -7, -8 and -9 as prognostic markers for survival in epithelial ovarian cancer: A systematic review and meta-analysis.
Pergialiotis V; Papoutsi E; Androutsou A; Tzortzis AS; Frountzas M; Papapanagiotou A; Kontzoglou K
Int J Gynaecol Obstet; 2021 Mar; 152(3):299-307. PubMed ID: 33156523
[TBL] [Abstract][Full Text] [Related]
7. Role of galectins in lung cancer.
Chang WA; Tsai MJ; Kuo PL; Hung JY
Oncol Lett; 2017 Nov; 14(5):5077-5084. PubMed ID: 29113148
[TBL] [Abstract][Full Text] [Related]
8. Galectins in the Tumor Microenvironment: Focus on Galectin-1.
MartÃnez-Bosch N; Navarro P
Adv Exp Med Biol; 2020; 1259():17-38. PubMed ID: 32578169
[TBL] [Abstract][Full Text] [Related]
9. Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients.
Schulz H; Schmoeckel E; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594391
[TBL] [Abstract][Full Text] [Related]
10. Galectin-1, -3 and -9 Expression and Clinical Significance in Squamous Cervical Cancer.
Punt S; Thijssen VL; Vrolijk J; de Kroon CD; Gorter A; Jordanova ES
PLoS One; 2015; 10(6):e0129119. PubMed ID: 26066796
[TBL] [Abstract][Full Text] [Related]
11. Role of Human Galectins in Inflammation and Cancers Associated with Endometriosis.
Hisrich BV; Young RB; Sansone AM; Bowens Z; Green LJ; Lessey BA; Blenda AV
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32033052
[TBL] [Abstract][Full Text] [Related]
12. [Galectin expression in urological cancer. Diagnostic, prognostic and therapeutic potential].
Waalkes S; Merseburger AS; Simon A; Serth J; Kuczyk MA
Urologe A; 2010 Mar; 49(3):387-91. PubMed ID: 20238481
[TBL] [Abstract][Full Text] [Related]
13. Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9.
Schulz H; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U; Schmoeckel E
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361803
[TBL] [Abstract][Full Text] [Related]
14. Roles of Galectin-7 in Cancer.
Kaur M; Kaur T; Kamboj SS; Singh J
Asian Pac J Cancer Prev; 2016; 17(2):455-61. PubMed ID: 26925627
[TBL] [Abstract][Full Text] [Related]
15. 90K (Mac-2 BP) and galectins in tumor progression and metastasis.
Grassadonia A; Tinari N; Iurisci I; Piccolo E; Cumashi A; Innominato P; D'Egidio M; Natoli C; Piantelli M; Iacobelli S
Glycoconj J; 2002; 19(7-9):551-6. PubMed ID: 14758079
[TBL] [Abstract][Full Text] [Related]
16. Intracellular galectins in cancer cells: potential new targets for therapy (Review).
Vladoiu MC; Labrie M; St-Pierre Y
Int J Oncol; 2014 Apr; 44(4):1001-14. PubMed ID: 24452506
[TBL] [Abstract][Full Text] [Related]
17. Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells.
Glinsky VV; Huflejt ME; Glinsky GV; Deutscher SL; Quinn TP
Cancer Res; 2000 May; 60(10):2584-8. PubMed ID: 10825125
[TBL] [Abstract][Full Text] [Related]
18. Galectins and galectin-mediated autophagy regulation: new insights into targeted cancer therapy.
Liu D; Zhu H; Li C
Biomark Res; 2023 Feb; 11(1):22. PubMed ID: 36814341
[TBL] [Abstract][Full Text] [Related]
19. A distinctive role for galectin-7 in cancer ?
St-Pierre Y; Campion CG; Grosset AA
Front Biosci (Landmark Ed); 2012 Jan; 17(2):438-50. PubMed ID: 22201754
[TBL] [Abstract][Full Text] [Related]
20. Role of Galectins in Tumors and in Clinical Immunotherapy.
Chou FC; Chen HY; Kuo CC; Sytwu HK
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
